Information for "Managing radioiodine refractory hypothyroid cancer the role associated with dosimetry and also redifferentiation on following I131 therapy"
From EECH Central
Basic information
Display title | Managing radioiodine refractory hypothyroid cancer the role associated with dosimetry and also redifferentiation on following I131 therapy |
Default sort key | Managing radioiodine refractory hypothyroid cancer the role associated with dosimetry and also redifferentiation on following I131 therapy |
Page length (in bytes) | 4,853 |
Page ID | 1322996 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Bakercoffee9 (Talk | contribs) |
Date of page creation | 10:39, 31 March 2024 |
Latest editor | Bakercoffee9 (Talk | contribs) |
Date of latest edit | 10:39, 31 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |